Search research articles
Contact Us
Filters
Showing results (381-390 of 542) with videos related to
Page
of 55
Sort By:
Journal of Clinical Microbiology
|
November 3, 2006
Use of fluconazole as a surrogate marker to predict susceptibility and resistance to voriconazole among 13,338 clinical isolates of Candida spp. Tested by clinical and laboratory standards institute-recommended broth microdilution methods
M A Pfaller, S A Messer, L Boyken, et al.
Diagnostic Microbiology and Infectious Disease
|
November 1, 1993
Application of genomic DNA subtyping by pulsed field gel electrophoresis and restriction enzyme analysis of plasmid DNA to characterize methicillin-resistant Staphylococcus aureus from two nosocomial outbreaks
M L Branchini, V H Morthland, A T Tresoldi, et al.
The Journal of Infectious Diseases
|
February 1, 1986
Usefulness of a test for slime production as a marker for clinically significant infections with coagulase-negative staphylococci
D S Davenport, R M Massanari, M A Pfaller, et al.
Journal of Clinical Microbiology
|
June 20, 2008
In vitro survey of triazole cross-resistance among more than 700 clinical isolates of Aspergillus species
M A Pfaller, S A Messer, L Boyken, et al.
Diagnostic Microbiology and Infectious Disease
|
July 1, 1991
Antimicrobial activity of cefpirome. An update compared to five third-generation cephalosporins against nearly 6000 recent clinical isolates from five medical centers
R N Jones, M A Pfaller, S D Allen, et al.
The Journal of Antimicrobial Chemotherapy
|
February 1, 1994
In-vitro activity of five beta-lactam/beta-lactamase inhibitor combinations against consecutive isolates of the Enterobacteriaceae and Pseudomonas aeruginosa
J C McLaughlin, A L Barry, P C Fuchs, et al.
Journal of Clinical Microbiology
|
October 1, 1993
Comparison of the Septi-Chek AFB and BACTEC systems and conventional culture for recovery of mycobacteria
D L Sewell, A L Rashad, W J Rourke, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 26, 2001
Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999
D J Diekema, M A Pfaller, F J Schmitz, et al.
Journal of Clinical Microbiology
|
July 1, 1994
Selection of candidate quality control isolates and tentative quality control ranges for in vitro susceptibility testing of yeast isolates by National Committee for Clinical Laboratory Standards proposed standard methods
M A Pfaller, M Bale, B Buschelman, et al.
Journal of Clinical Microbiology
|
July 10, 2004
Further standardization of broth microdilution methodology for in vitro susceptibility testing of caspofungin against Candida species by use of an international collection of more than 3,000 clinical isolates
M A Pfaller, S A Messer, L Boyken, et al.
Page
of 55
Search research articles
Search
Showing results (381-390 of 542) with videos related to
Sort By:
Page
of 55
Journal of Clinical Microbiology
|
November 3, 2006
Use of fluconazole as a surrogate marker to predict susceptibility and resistance to voriconazole among 13,338 clinical isolates of Candida spp. Tested by clinical and laboratory standards institute-recommended broth microdilution methods
M A Pfaller, S A Messer, L Boyken, et al.
Diagnostic Microbiology and Infectious Disease
|
November 1, 1993
Application of genomic DNA subtyping by pulsed field gel electrophoresis and restriction enzyme analysis of plasmid DNA to characterize methicillin-resistant Staphylococcus aureus from two nosocomial outbreaks
M L Branchini, V H Morthland, A T Tresoldi, et al.
The Journal of Infectious Diseases
|
February 1, 1986
Usefulness of a test for slime production as a marker for clinically significant infections with coagulase-negative staphylococci
D S Davenport, R M Massanari, M A Pfaller, et al.
Journal of Clinical Microbiology
|
June 20, 2008
In vitro survey of triazole cross-resistance among more than 700 clinical isolates of Aspergillus species
M A Pfaller, S A Messer, L Boyken, et al.
Diagnostic Microbiology and Infectious Disease
|
July 1, 1991
Antimicrobial activity of cefpirome. An update compared to five third-generation cephalosporins against nearly 6000 recent clinical isolates from five medical centers
R N Jones, M A Pfaller, S D Allen, et al.
The Journal of Antimicrobial Chemotherapy
|
February 1, 1994
In-vitro activity of five beta-lactam/beta-lactamase inhibitor combinations against consecutive isolates of the Enterobacteriaceae and Pseudomonas aeruginosa
J C McLaughlin, A L Barry, P C Fuchs, et al.
Journal of Clinical Microbiology
|
October 1, 1993
Comparison of the Septi-Chek AFB and BACTEC systems and conventional culture for recovery of mycobacteria
D L Sewell, A L Rashad, W J Rourke, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 26, 2001
Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999
D J Diekema, M A Pfaller, F J Schmitz, et al.
Journal of Clinical Microbiology
|
July 1, 1994
Selection of candidate quality control isolates and tentative quality control ranges for in vitro susceptibility testing of yeast isolates by National Committee for Clinical Laboratory Standards proposed standard methods
M A Pfaller, M Bale, B Buschelman, et al.
Journal of Clinical Microbiology
|
July 10, 2004
Further standardization of broth microdilution methodology for in vitro susceptibility testing of caspofungin against Candida species by use of an international collection of more than 3,000 clinical isolates
M A Pfaller, S A Messer, L Boyken, et al.
Page
of 55